Healthcare Stocks Perk Up Amidst the Speculative Fervor-Risk On…Update-4…EDIT,SGMO.
Update-4 12/10....Nice snapback rally in NASDAQ up 0.54% with many nice moves in gene therapy from ASH. XBI up 3.69% ASH gives us two big wins : EDIT up 32% on IND application for sickle disease; Sangamo (SGMO) up 50% on Hemophilia A gene therapy. Gene therapy covered at JPM . Core biotech...
November Rally In Biotech with Small Caps Taking Off
November Rally in Biotech and with Broadening to Other Sectors Small caps taking off including XBI up 12%, IWM up 16.5% (11.2% YTD). Healthcare lagging a bit with the XLV up only 3.35% vs SPY up 7.5% (12.6% YTD). Re-openng trade movers: XLI up 14.75% at $88.11; XLE up 34.54% at $38.91. The...
Large Cap Biopharma Performance and Metrics Q3 2020; ETFs Are Winners-Update-3
Update-3 11/27 12p EST....Biotech rally underway with XBI at $130. Momentum market.IBB at 142.94.Small caps outpacing large caps. Vaccine stocks continue to run: BNTX, MRNA, NVAX. Gene editing movers : CRSP, EDIT, NTLA; mid caps strong. Large caps winners: AMGN VRTX Update-2 11/24..Another...
Re-Opening Trade is On Despite a Backdrop of COVID Cases Surging…Update-1
Update-1 11/20...a bit of a sell-off at the end of the day probably on Mnuchin "war of words" with FED on $500B. "Re-opening type" trades in XLF and XLI both down 0.9%;XLK down 1%. Materials doing well CLF, FCX; chips mixed slightly down. IBB and XBI up a tad; large cap winners...
Healthcare Portfolio Performance: Small Stocks Perk Up !…Update-1
Update-1 11/16 ...Healthcare Stocks Underperform-Rotation or Head- Fake? Many of our picks are up over 10% in two weeks so it is not surprising that momentum has eased.However the market has pivoted over the past few days on the expectation of COVID vaccine availability for 2021. The big news...